178 related articles for article (PubMed ID: 37978342)
1. Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience.
Deantoni CL; Mirabile A; Chiara A; Giannini L; Midulla M; Del Vecchio A; Fiorino C; Fodor A; Di Muzio NG; Dell'Oca I
Tumori; 2024 Apr; 110(2):116-123. PubMed ID: 37978342
[TBL] [Abstract][Full Text] [Related]
2. Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
Nagpal P; Pruthi DS; Pandey M; Yadav A; Singh H
Oral Oncol; 2021 Oct; 121():105483. PubMed ID: 34403887
[TBL] [Abstract][Full Text] [Related]
3. Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia During Chemoradiotherapy.
Endo K; Ueno T; Hirai N; Komori T; Nakanishi Y; Kondo S; Wakisaka N; Yoshizaki T
Laryngoscope; 2021 May; 131(5):E1524-E1529. PubMed ID: 33030229
[TBL] [Abstract][Full Text] [Related]
4. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy.
van Rijn-Dekker MI; van den Bosch L; van den Hoek JGM; Bijl HP; van Aken ESM; van der Hoorn A; Oosting SF; Halmos GB; Witjes MJH; van der Laan HP; Langendijk JA; Steenbakkers RJHM
Radiother Oncol; 2020 Jun; 147():103-110. PubMed ID: 32251949
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
6. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
Ganju RG; Morse R; Hoover A; TenNapel M; Lominska CE
Radiother Oncol; 2019 Aug; 137():117-124. PubMed ID: 31085391
[TBL] [Abstract][Full Text] [Related]
7. Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study.
Lee J; Liu SH; Chen JC; Leu YS; Liu CJ; Chen YJ
Radiother Oncol; 2021 May; 158():83-89. PubMed ID: 33621588
[TBL] [Abstract][Full Text] [Related]
8. Impact of Low Skeletal Muscle Mass on the Prognosis of Patients with Head and Neck Cancer Treated Nonsurgically.
Iwasa YI; Kitoh R; Hiramatsu K; Sugiyama K; Watanabe K; Yasukawa R; Shinagawa J; Miyajima H; Yokota Y; Kobayashi M; Kitano T; Mori K; Takumi Y
ORL J Otorhinolaryngol Relat Spec; 2023; 85(1):36-43. PubMed ID: 36423591
[TBL] [Abstract][Full Text] [Related]
9. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
12. Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy.
Aichi M; Hasegawa S; Kurita Y; Shinoda S; Kato S; Mizushima T; Yokota NR; Miyagi E
Nutrition; 2023 May; 109():111966. PubMed ID: 36731243
[TBL] [Abstract][Full Text] [Related]
13. Fully-automated sarcopenia assessment in head and neck cancer: development and external validation of a deep learning pipeline.
Ye Z; Saraf A; Ravipati Y; Hoebers F; Zha Y; Zapaishchykova A; Likitlersuang J; Tishler RB; Schoenfeld JD; Margalit DN; Haddad RI; Mak RH; Naser M; Wahid KA; Sahlsten J; Jaskari J; Kaski K; Mäkitie AA; Fuller CD; Aerts HJWL; Kann BH
medRxiv; 2023 Mar; ():. PubMed ID: 36945519
[TBL] [Abstract][Full Text] [Related]
14. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Smee R; Moses D; Bauer J
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
[TBL] [Abstract][Full Text] [Related]
15. Low Skeletal Muscle Mass before Salvage-Line Chemotherapy Is a Poor Prognostic Factor in Patients with Refractory Metastatic Colorectal Cancer.
Miyamoto Y; Hiyoshi Y; Akiyama T; Kiyozumi Y; Eto K; Yohei N; Iwagami S; Baba Y; Yoshida N; Baba H
Digestion; 2019; 99(1):79-85. PubMed ID: 30554226
[TBL] [Abstract][Full Text] [Related]
16. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
17. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
[TBL] [Abstract][Full Text] [Related]
18. Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
de Roest RH; van der Heijden M; Wesseling FWR; de Ruiter EJ; Heymans MW; Terhaard C; Vergeer MR; Buter J; Devriese LA; de Boer JP; Navran A; Hoeben A; Vens C; van den Brekel M; Brakenhoff RH; Leemans CR; Hoebers F
Radiother Oncol; 2022 Oct; 175():112-121. PubMed ID: 35973619
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
20. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
